BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1073 related articles for article (PubMed ID: 30949776)

  • 1. Bacteriophage PEV20 and Ciprofloxacin Combination Treatment Enhances Removal of Pseudomonas aeruginosa Biofilm Isolated from Cystic Fibrosis and Wound Patients.
    Chang RYK; Das T; Manos J; Kutter E; Morales S; Chan HK
    AAPS J; 2019 Apr; 21(3):49. PubMed ID: 30949776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergy of nebulized phage PEV20 and ciprofloxacin combination against Pseudomonas aeruginosa.
    Lin Y; Chang RYK; Britton WJ; Morales S; Kutter E; Chan HK
    Int J Pharm; 2018 Nov; 551(1-2):158-165. PubMed ID: 30223075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergistic activity of phage PEV20-ciprofloxacin combination powder formulation-A proof-of-principle study in a P. aeruginosa lung infection model.
    Lin Y; Quan D; Chang RYK; Chow MYT; Wang Y; Li M; Morales S; Britton WJ; Kutter E; Li J; Chan HK
    Eur J Pharm Biopharm; 2021 Jan; 158():166-171. PubMed ID: 33253892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. P. aeruginosa flow-cell biofilms are enhanced by repeated phage treatments but can be eradicated by phage-ciprofloxacin combination.
    Henriksen K; Rørbo N; Rybtke ML; Martinet MG; Tolker-Nielsen T; Høiby N; Middelboe M; Ciofu O
    Pathog Dis; 2019 Mar; 77(2):. PubMed ID: 30821815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bacteriophages φMR299-2 and φNH-4 can eliminate Pseudomonas aeruginosa in the murine lung and on cystic fibrosis lung airway cells.
    Alemayehu D; Casey PG; McAuliffe O; Guinane CM; Martin JG; Shanahan F; Coffey A; Ross RP; Hill C
    mBio; 2012; 3(2):e00029-12. PubMed ID: 22396480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhalable combination powder formulations of phage and ciprofloxacin for P. aeruginosa respiratory infections.
    Lin Y; Chang RYK; Britton WJ; Morales S; Kutter E; Li J; Chan HK
    Eur J Pharm Biopharm; 2019 Sep; 142():543-552. PubMed ID: 31398437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activity of Bacteriophages in Removing Biofilms of
    Fong SA; Drilling A; Morales S; Cornet ME; Woodworth BA; Fokkens WJ; Psaltis AJ; Vreugde S; Wormald PJ
    Front Cell Infect Microbiol; 2017; 7():418. PubMed ID: 29018773
    [No Abstract]   [Full Text] [Related]  

  • 8. Phage-antibiotic combinations against multidrug-resistant
    Holger DJ; El Ghali A; Bhutani N; Lev KL; Stamper K; Kebriaei R; Kunz Coyne AJ; Morrisette T; Shah R; Alexander J; Lehman SM; Rojas LJ; Marshall SH; Bonomo RA; Rybak MJ
    Antimicrob Agents Chemother; 2023 Nov; 67(11):e0057823. PubMed ID: 37855639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unveiling the early events of Pseudomonas aeruginosa adaptation in cystic fibrosis airway environment using a long-term in vitro maintenance.
    Sousa AM; Monteiro R; Pereira MO
    Int J Med Microbiol; 2018 Dec; 308(8):1053-1064. PubMed ID: 30377031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design of a Broad-Range Bacteriophage Cocktail That Reduces Pseudomonas aeruginosa Biofilms and Treats Acute Infections in Two Animal Models.
    Forti F; Roach DR; Cafora M; Pasini ME; Horner DS; Fiscarelli EV; Rossitto M; Cariani L; Briani F; Debarbieux L; Ghisotti D
    Antimicrob Agents Chemother; 2018 Jun; 62(6):. PubMed ID: 29555626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bacteriophage Delivery by Nebulization and Efficacy Against Phenotypically Diverse Pseudomonas aeruginosa from Cystic Fibrosis Patients.
    Sahota JS; Smith CM; Radhakrishnan P; Winstanley C; Goderdzishvili M; Chanishvili N; Kadioglu A; O'Callaghan C; Clokie MR
    J Aerosol Med Pulm Drug Deliv; 2015 Oct; 28(5):353-60. PubMed ID: 25714328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improving the Inhibitory Effect of Phages against
    Aghaee BL; Khan Mirzaei M; Alikhani MY; Mojtahedi A; Maurice CF
    Viruses; 2021 Feb; 13(2):. PubMed ID: 33670028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determining effects of nitrate, arginine, and ferrous on antibiotic recalcitrance of clinical strains of Pseudomonas aeruginosa in biofilm-inspired alginate encapsulates.
    Jabalameli F; Emaneini M; Beigverdi R; Halimi S; Siroosi M
    Ann Clin Microbiol Antimicrob; 2023 Jul; 22(1):61. PubMed ID: 37475017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phage-antibiotic combinations to control Pseudomonas aeruginosa-Candida two-species biofilms.
    Manohar P; Loh B; Nachimuthu R; Leptihn S
    Sci Rep; 2024 Apr; 14(1):9354. PubMed ID: 38653744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formation of hydroxyl radicals contributes to the bactericidal activity of ciprofloxacin against Pseudomonas aeruginosa biofilms.
    Jensen PØ; Briales A; Brochmann RP; Wang H; Kragh KN; Kolpen M; Hempel C; Bjarnsholt T; Høiby N; Ciofu O
    Pathog Dis; 2014 Apr; 70(3):440-3. PubMed ID: 24376174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination antibiotic susceptibility of biofilm-grown Burkholderia cepacia and Pseudomonas aeruginosa isolated from patients with pulmonary exacerbations of cystic fibrosis.
    Dales L; Ferris W; Vandemheen K; Aaron SD
    Eur J Clin Microbiol Infect Dis; 2009 Oct; 28(10):1275-9. PubMed ID: 19575248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of Calgary and Microfluidic BioFlux Systems To Test the Activity of Fosfomycin and Tobramycin Alone and in Combination against Cystic Fibrosis Pseudomonas aeruginosa Biofilms.
    Díez-Aguilar M; Morosini MI; Köksal E; Oliver A; Ekkelenkamp M; Cantón R
    Antimicrob Agents Chemother; 2018 Jan; 62(1):. PubMed ID: 29084746
    [No Abstract]   [Full Text] [Related]  

  • 18. Antibiotic susceptabilities of Pseudomonas aeruginosa isolates derived from patients with cystic fibrosis under aerobic, anaerobic, and biofilm conditions.
    Hill D; Rose B; Pajkos A; Robinson M; Bye P; Bell S; Elkins M; Thompson B; Macleod C; Aaron SD; Harbour C
    J Clin Microbiol; 2005 Oct; 43(10):5085-90. PubMed ID: 16207967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pseudomonas biofilms, cystic fibrosis, and phage: a silver lining?
    Brüssow H
    mBio; 2012; 3(2):. PubMed ID: 22493030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro and in vivo antibacterial activity of environmental bacteriophages against Pseudomonas aeruginosa strains from cystic fibrosis patients.
    Olszak T; Zarnowiec P; Kaca W; Danis-Wlodarczyk K; Augustyniak D; Drevinek P; de Soyza A; McClean S; Drulis-Kawa Z
    Appl Microbiol Biotechnol; 2015 Jul; 99(14):6021-33. PubMed ID: 25758956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 54.